Actively Recruiting
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Led by Daewoong Pharmaceutical Co. LTD. · Updated on 2025-01-23
12000
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study is a non-interventional, multi-center, prospective observational study aimed at tracking the efficacy and safety of Envlo or Envlomet SR tablets for 24 weeks in patients with type 2 diabetes and hypertension or dyslipidemia who are currently taking or are scheduled to take Envlo or Envlomet SR tablets in an actual clinical setting.
CONDITIONS
Official Title
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older
- Diagnosed with type 2 diabetes and have hypertension or dyslipidemia
- Currently receiving or scheduled to receive Envlo Tablet or Envlomet SR Tablet
- Voluntarily agree to participate and comply with study precautions
- Understand the study and are capable of completing it
You will not qualify if you...
- Patients starting Envlo or Envlomet treatment with an eGFR less than 60 ml/min/1.73m²
- Patients with diabetes other than type 2 (such as type 1 diabetes, diabetic ketoacidosis, gestational diabetes)
- Those prohibited from taking Envlo due to allergy or adverse reaction
- Patients with end-stage kidney disease or on dialysis
- Patients with moderate to severe liver failure
- Patients classified as Class III or IV by New York Heart Association
- Patients with unstable weight due to treatments or medications within 3 months
- Pregnant or breastfeeding women
- Participants currently in other clinical trials involving drugs or devices
- Anyone deemed unsuitable for the study by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Happy Yonsei Family Medicine Clinic
Seoul, South Korea, 12254
Actively Recruiting
Research Team
J
Ji Yeon Baeg
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here